Home

Ebook

Segmentation and Targeting: A Modern Data Approach for Today's Complex Therapies

Segmentation and Targeting: A Modern Data Approach for Today's Complex Therapies

Veeva

Three out of four drug launches fail to meet forecasts, costing an average of $200 million in lost sales per asset. Rising competition and shrinking product life cycles intensify the pressure on teams to reach healthcare providers (HCPs) pre-launch with resonant messaging. Veeva software empowers biopharmas to expand and accelerate segmentation and targeting through an integrated, modern data approach, enabling efficient, impactful HCP interactions that drive higher engagement, adherence, and ultimately better patient outcomes.

Join for free to read

You Might Also Like


Modern Patient Data for Today’s Complex Therapies
Vendor Sheet Modern Patient Data for Today’s Complex Therapies
Veeva

Patient and Prescriber Data for Segmentation & Targeting
Vendor Sheet Patient and Prescriber Data for Segmentation & Targeting
Veeva

Enhancing Physician Segmentation and Targeting with a Patient-Centric Approach
Case Study Enhancing Physician Segmentation and Targeting with a…
IQVIA

Managing Complex Sample and IP Logistics in Support of Cell and Gene Therapies
Ebook Managing Complex Sample and IP Logistics in Support of Cell and…
PPD

More from Veeva


Modern Patient Data for Today’s Complex Therapies
Vendor Sheet Modern Patient Data for Today’s Complex Therapies
Veeva

Patient and Prescriber Data for Segmentation & Targeting
Vendor Sheet Patient and Prescriber Data for Segmentation & Targeting
Veeva

Data and Platform Needs to Prepare for a Rare Disease Launch
Case Study Data and Platform Needs to Prepare for a Rare Disease Launch
Veeva

Supporting Complex Protocols with an Integrated EDC and IRT Solution
Case Study Supporting Complex Protocols with an Integrated EDC and IRT…
Veeva
© 2026 Contentree.  All Rights Reserved   |   Privacy and Cookies   |   Legal   |   Do not sell my info